<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04786145</url>
  </required_header>
  <id_info>
    <org_study_id>COPE</org_study_id>
    <nct_id>NCT04786145</nct_id>
  </id_info>
  <brief_title>Cryoneurolysis Outcome on Pain Experience (COPE) in Patients With Low-back Pain</brief_title>
  <acronym>COPE</acronym>
  <official_title>Cryoneurolysis Outcome on Pain Experience (COPE) in Patients With Low-back Pain - a Single-blinded Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will provide information on the effectiveness of cryoneurolysis for patients with&#xD;
      facet joint pain syndrome, and help to establish whether cryoneurolysis should be implemented&#xD;
      in clinical practice for this patient population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Low-back pain, including facet joint pain, accounts for up to 20 percent of all&#xD;
      sick leaves in Denmark; among these are patients with facet joint pain syndrome. A proposed&#xD;
      treatment option is cryoneurolysis. This study aims to investigate the effect of&#xD;
      cryoneurolysis in lumbar facet joint pain syndrome&#xD;
&#xD;
      Methods: A single-center randomized controlled trial (RCT) is performed including 120&#xD;
      participants with chronic facet joint pain syndrome, referred to the Department of&#xD;
      Neurosurgery, Aarhus University Hospital. Eligible patients receive a diagnostic anesthetic&#xD;
      block, where a reduction of pain intensity &gt;50 % on a numerical rating scale (NRS) is&#xD;
      required to be enrolled. Participants are randomized into three groups to undergo either one&#xD;
      treatment of cryoneurolysis, radiofrequency ablation or placebo. Fluoroscopy and sensory&#xD;
      stimulation is used to identify the intended target nerve prior to administrating the&#xD;
      above-mentioned treatments. All groups receive physiotherapy for 6 weeks, starting 4 weeks&#xD;
      after treatment. The primary outcome is a reduction in low-back pain intensity and an&#xD;
      impression of change in pain after intervention (Patient Global Impression of Change (PGIC))&#xD;
      at 4 weeks follow-up, prior to physiotherapy. Secondary outcomes are quality of life (EQ-5D,&#xD;
      SF-36) and level of function (Oswestry Disability Index), psychological perception of pain&#xD;
      (Pain Catastrophizing Scale) and depression status (Major Depression Inventory). Data will be&#xD;
      assessed at baseline (T0), randomization (T1), day one (T2), 4 weeks (T3), 3 (T4), 6 (T5) and&#xD;
      12 months&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study is a single-center, blinded randomized controlled trial with two intervention arms and one placebo arm with allocation ratio of 1:1:1. One group receives one treatment of cryoneurolysis, the second group receives radiofrequency ablation and the third group receives placebo (control group).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Outcomes Assessors, physiotherapists and participants are blinded to the intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The effect of the intervention, assessed by Patient Global Impression of Change (PGIC) at 4 weeks follow-up</measure>
    <time_frame>4 weeks</time_frame>
    <description>The Patient Global Impression of Change (PGIC) is a 7-point patient self-reporting scale of overall improvement after treatment ranging from 1) very much improved, 2) much improved, 3) minimally improved, 4) no change, 5) minimally worse, 6) much worse, or 7) very much worse</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Global Impression of Change (PGIC) at day one, three, six and 12 months follow-up.</measure>
    <time_frame>1-12 months</time_frame>
    <description>The Patient Global Impression of Change (PGIC) is a 7-point patient self-reporting scale of overall improvement after treatment ranging from 1) very much improved, 2) much improved, 3) minimally improved, 4) no change, 5) minimally worse, 6) much worse, or 7) very much worse.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Numeric Rating Scale (NRS-11) from baseline to day one, four weeks, three, six and 12 months follow-up</measure>
    <time_frame>1-12 months</time_frame>
    <description>The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain from 0 no pain to 10 worst pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Pain Catastrophizing Scale (PCS) at baseline, four weeks, three, six and 12 months follow-up</measure>
    <time_frame>1-12 months</time_frame>
    <description>The Pain Catastrophizing Scale (PCS) assesses the extent of catastrophic thinking due to low back pain according to 3 components: rumination, magnification, and helplessness.&#xD;
It is a self-report measure, consisting of 13 items scored from 0 to 4, resulting in a total possible score of 52. The higher the score, the more catastrophizing thoughts are present.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to six and 12 months follow-up in the Oswestry Disability Index (ODI).</measure>
    <time_frame>1-12 months</time_frame>
    <description>The Owestry Disability Index (ODI) comprises 10 sections with 5 questions in each to measure a patient's permanent functional disability. For each section the scores range of 0 to 5, resulting in a total possible score of 50. If all 10 sections are completed the score is calculated as follows: if 16 (total scored) out of 50 (total possible score) x 100 = 32%. The higher the calculated percentage, the more severe the disability is.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to six and 12 months follow-up in the European Quality of Life - 5 Dimensions (EQ5D)</measure>
    <time_frame>1-12 months</time_frame>
    <description>The European Quality of Life - 5 Dimensions (EQ5D) comprises five questions on mobility, self care, pain, usual activities, and psychological status with three possible answers for each item (1=no problem, 2=moderate problem, 3=severe problem. A summary index with a maximum score of 1 can be derived from these five dimensions by conversion with a table of scores. The maximum score of 1 indicates the best health state, in each dimension, where higher scores indicate more severe. In addition, there is a visual analogue scale (VAS) to indicate the general health status with 100 indicating the best health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to 12 months follow-up for change in Major Depression Inventory (MDI) and the Short Form (36) Health Survey (SF-36)</measure>
    <time_frame>1-12 months</time_frame>
    <description>The Major Depression Inventory (MDI) is a self-reporting measure to assess the presence and severity of a depressive disorder. It consists of 10 questions with a total possible score of 50.&#xD;
A score of under 20 indicates no depression and a score of more than 29 indicates severe depression.&#xD;
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. it consists of 8 scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale. The lower the score the more disability while higher scores indicate the less disability .The maximum score of 100 indicates the best possible health state.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Chronic Low-back Pain</condition>
  <condition>Facet Joint Pain</condition>
  <condition>Degeneration Lumbar Spine</condition>
  <condition>Facet Joint Syndrome</condition>
  <condition>Back Pain Lower Back Chronic</condition>
  <arm_group>
    <arm_group_label>Cryoneurolysis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 patients are randomized to receive one treatment of cryoneurolysis on the facet joints of three lumbar level corresponding to their facet joint pain generator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiofrequency ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 patients are randomized to receive one treatment of radiofrequency ablation on the facet joints of three lumbar level corresponding to their facet joint pain generator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>40 patients are randomized to receive sham treatment. Subjected to similar procedures as cryoneurolysis and radiofrequency ablation, but without active treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cryoneurolysis</intervention_name>
    <description>This is a medical procedure that temporarily blocks nerve conduction along peripheral nerve pathways by freezing it. Small probe is inserted in order to freeze the target nerve, can facilitate complete regeneration of the structure and function of the affected nerve.</description>
    <arm_group_label>Cryoneurolysis</arm_group_label>
    <other_name>cryoanalgesia</other_name>
    <other_name>cryoneuroablation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency ablation</intervention_name>
    <description>This is a medical procedure that temporarily blocks nerve conduction along peripheral nerve pathways. Small needle with an active heating tip is inserted, to destroy the functionality of the target nerve using heat from radiofrequency energy.</description>
    <arm_group_label>Radiofrequency ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>No active treatment is given.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Low-back pain from facet joint syndrom (facet joint pain) &gt; 3 months' duration with or&#xD;
             without neuropathic pain component.&#xD;
&#xD;
          -  Low-back pain on Numeric Rating Scale ≥ 4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of nerve root or spinal canal compression; signs of inflammatory or erosive&#xD;
             processes in the spine verified on magnetic resonance imaging (MRI).&#xD;
&#xD;
          -  Neurological deficits i.e. symptoms of nerve root compression; tingling, numbness,&#xD;
             weakness/ paresis, and reflex loss in the lower extremities.&#xD;
&#xD;
          -  Major co-morbidity.&#xD;
&#xD;
          -  Anti-thrombotic or anti-platelet treatment which cannot be paused for a week.&#xD;
&#xD;
          -  Active malignancies.&#xD;
&#xD;
          -  Chronic inflammatory disease.&#xD;
&#xD;
          -  Known severe psychiatric disease. Patients with mild and well-treated depression and&#xD;
             anxiety are not excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaare Meier, MD, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lone Nikolajsen, M.D, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurits Van Tulder, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jens Christian H Sørensen, M.D, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kamilla My Truong, M.D</last_name>
    <phone>+4542321578</phone>
    <email>kamilla.truong@clin.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mikkel M Rasmussen, MD, Ph.D</last_name>
    <email>mikkrasm@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurosurgery, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Central Denmark</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>kamilla My Truong, MD</last_name>
      <phone>+4542321578</phone>
      <email>kamilla.truong@clin.au.dk</email>
    </contact>
    <contact_backup>
      <last_name>Mikkel M Mylius, MD, Ph.D.</last_name>
      <email>mikkrasm@rm.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Sundhedsstyrelsen. Anbefalinger for tværsektorielle forløb for mennesker med kroniske lænderygsmerter. 2017 Pdf;1(1.1):1-38.</citation>
  </reference>
  <reference>
    <citation>Binder DS, Nampiaparampil DE. The provocative lumbar facet joint. Curr Rev Musculoskelet Med. 2009 Mar;2(1):15-24. doi: 10.1007/s12178-008-9039-y. Epub 2009 Mar 31.</citation>
    <PMID>19468914</PMID>
  </reference>
  <reference>
    <citation>Trescot AM. Cryoanalgesia in interventional pain management. Pain Physician. 2003 Jul;6(3):345-60.</citation>
    <PMID>16880882</PMID>
  </reference>
  <reference>
    <citation>Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006 Oct;22(10):1911-20.</citation>
    <PMID>17022849</PMID>
  </reference>
  <reference>
    <citation>Schmidt CO, Schweikert B, Wenig CM, Schmidt U, Gockel U, Freynhagen R, Tölle TR, Baron R, Kohlmann T. Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain. 2009 Nov;13(10):1030-5. doi: 10.1016/j.ejpain.2008.12.003. Epub 2009 Feb 6.</citation>
    <PMID>19201230</PMID>
  </reference>
  <reference>
    <citation>Cohen SP, Raja SN. Pathogenesis, diagnosis, and treatment of lumbar zygapophysial (facet) joint pain. Anesthesiology. 2007 Mar;106(3):591-614. Review.</citation>
    <PMID>17325518</PMID>
  </reference>
  <reference>
    <citation>Wolter T, Deininger M, Hubbe U, Mohadjer M, Knoeller S. Cryoneurolysis for zygapophyseal joint pain: a retrospective analysis of 117 interventions. Acta Neurochir (Wien). 2011 May;153(5):1011-9. doi: 10.1007/s00701-011-0966-9. Epub 2011 Feb 26.</citation>
    <PMID>21359539</PMID>
  </reference>
  <reference>
    <citation>Birkenmaier C, Veihelmann A, Trouillier H, Hausdorf J, Devens C, Wegener B, Jansson V, von Schulze Pellengahr C. Percutaneous cryodenervation of lumbar facet joints: a prospective clinical trial. Int Orthop. 2007 Aug;31(4):525-30. Epub 2006 Aug 23.</citation>
    <PMID>16927087</PMID>
  </reference>
  <reference>
    <citation>Bellini M, Barbieri M. Percutaneous cryoanalgesia in pain management: a case-series. Anaesthesiol Intensive Ther. 2015;47(4):333-5. doi: 10.5603/AIT.2015.0045.</citation>
    <PMID>26401741</PMID>
  </reference>
  <reference>
    <citation>Birkenmaier C, Veihelmann A, Trouillier HH, Hausdorf J, von Schulze Pellengahr C. Medial branch blocks versus pericapsular blocks in selecting patients for percutaneous cryodenervation of lumbar facet joints. Reg Anesth Pain Med. 2007 Jan-Feb;32(1):27-33.</citation>
    <PMID>17196489</PMID>
  </reference>
  <reference>
    <citation>Maas ET, Ostelo RW, Niemisto L, Jousimaa J, Hurri H, Malmivaara A, van Tulder MW. Radiofrequency denervation for chronic low back pain. Cochrane Database Syst Rev. 2015 Oct 23;(10):CD008572. doi: 10.1002/14651858.CD008572.pub2. Review.</citation>
    <PMID>26495910</PMID>
  </reference>
  <reference>
    <citation>Kapural L, Provenzano D, Narouze S. RE: Juch JNS, et al. Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back Pain: The Mint Randomized Clinical Trials. JAMA 2017;318(1):68-81. Neuromodulation. 2017 Dec;20(8):844. doi: 10.1111/ner.12729.</citation>
    <PMID>29220124</PMID>
  </reference>
  <reference>
    <citation>Lee CH, Chung CK, Kim CH. The efficacy of conventional radiofrequency denervation in patients with chronic low back pain originating from the facet joints: a meta-analysis of randomized controlled trials. Spine J. 2017 Nov;17(11):1770-1780. doi: 10.1016/j.spinee.2017.05.006. Epub 2017 May 30. Review.</citation>
    <PMID>28576500</PMID>
  </reference>
  <reference>
    <citation>Leggett LE, Soril LJ, Lorenzetti DL, Noseworthy T, Steadman R, Tiwana S, Clement F. Radiofrequency ablation for chronic low back pain: a systematic review of randomized controlled trials. Pain Res Manag. 2014 Sep-Oct;19(5):e146-53. Epub 2014 Jul 28. Review.</citation>
    <PMID>25068973</PMID>
  </reference>
  <reference>
    <citation>Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001 Nov;94(2):149-158. doi: 10.1016/S0304-3959(01)00349-9.</citation>
    <PMID>11690728</PMID>
  </reference>
  <reference>
    <citation>Paulsen RT, Carreon L, Busch F, Isenberg-Jørgensen A. A pilot cohort study of lumbar facet joint denervation in patients with chronic low-back pain. Dan Med J. 2019 Mar;66(3). pii: A5533.</citation>
    <PMID>30864544</PMID>
  </reference>
  <reference>
    <citation>Perrot S, Lantéri-Minet M. Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice. Eur J Pain. 2019 Jul;23(6):1117-1128. doi: 10.1002/ejp.1378. Epub 2019 Mar 18.</citation>
    <PMID>30793414</PMID>
  </reference>
  <reference>
    <citation>Correll DJ. The Measurement of Pain: Objectifying the Subjective. Pain Management volume 1, 2007, Pages 197-211</citation>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>low-back pain</keyword>
  <keyword>cryoneurolysis on lower-back pain</keyword>
  <keyword>Cryoanalgesia</keyword>
  <keyword>Cryoneurolysis</keyword>
  <keyword>Cryoneuroablation</keyword>
  <keyword>Radiofrequency ablation.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthralgia</mesh_term>
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

